The U.S. Department of Health and Human Services (HHS) has received more than 30 million doses of antimalarial drugs believed capable of treating coronavirus and the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) Saturday to release those drugs to coronavirus patients.
HHS announced Sunday it had accepted 30 million doses of hydroxychloroquine sulfate from Sandoz and one million doses of chloroquine phosphate from Bayer Pharmaceuticals intended for use in treating coronavirus patients after the FDA’s authorization. The authorization only approves the treatment under emergency circumstances, and not for normal, typical use. The drugs are not proven to be a cure or a vaccine for coronavirus.
The drug doses were being stored in the Strategic National Stockpile for medicines but will be distributed to hospitals to treat certain coronavirus patients.
President Donald Trump had previously touted various forms of antimalarial drugs, including chloroquine and hydroxychloroquine as promising treatments for coronavirus patients. In a March 19 press conference, Trump said the FDA was working quickly to review those treatments for approval in treating coronavirus patients, and that some patients were already being given the experimental treatments under “compassionate use” guidelines.
-Read more here: https://americanmilitarynews.com/2020/03/fda-approves-emergency-coronavirus-treatment-30-million-doses-of-anti-malaria-drugs/?utm_campaign=DailyEmails&utm_source=AM_Email&utm_medium=email